SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS

European Journal of Clinical Investigation

Volumn 39, Issue 7, 2009, Pages 618-625

  Oudit, G Y ^a   Kassiri, Z ^a   Jiang, C ^b   Liu, P P ^c   Poutanen, S M ^d   Penninger, J M ^e   Butany, J ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Angiotensin converting enzyme 2; Heart; Macrophage; SARS coronar virus; Severe acute respiratory syndrome

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; MESSENGER RNA;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; ENCEPHALOMYOCARDITIS VIRUS; EPIDEMIC; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS MYOCARDITIS; VIRUS STRAIN;

ANIMALS; AUTOPSY; CARDIOVASCULAR DISEASES; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; SARS VIRUS; VIRUS ACTIVATION;

EID: 66849134954     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02153.x     Document Type: Article

References (33)

1. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE et al. Angiotensinconverting enzyme 2 is an essential regulator of heart function. Nature 2002 417 : 822 8.
2. Oudit GY, Crackower MA, Backx PH, Penninger JM. The role of ACE2 in cardiovascular physiology. Trends Cardiovasc Med 2003 13 : 93 101. (Pubitemid 36411803)
3. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 2007 75 : 29 39. (Pubitemid 46873522)
4. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R et al. Loss of angiotensinconverting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 2006 168 : 1808 20.
5. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B et al. Angiotensin- converting enzyme 2 protects from severe acute lung failure. Nature 2005 436 : 112 6.
6. Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M et al. Deletion of angiotensinconverting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 2006 47 : 718 26.
7. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, Liu QC et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007 171 : 438 51.
8. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003 426 : 450 4.
9. Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci 2004 25 : 291 4.
10. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005 11 : 875 9.
11. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003 349 : 2431 41.
12. Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med 2004 10 : S88 97.
13. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003 289 : 2801 9.
14. Fowler RA, Lapinsky SE, Hallett D, Detsky AS, Sibbald WJ, Slutsky AS et al. Critically ill patients with severe acute respiratory syndrome. JAMA 2003 290 : 367 73.
15. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003 348 : 1995 2005. (Pubitemid 36569988)
16. Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis 2005 191 : 193 7.
17. Li SS, Cheng CW, Fu CL, Chan YH, Lee MP, Chan JW et al. Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study. Circulation 2003 108 : 1798 803.
18. Yu CM, Wong RS, Wu EB, Kong SL, Wong J, Yip GW et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J 2006 82 : 140 4.
19. Dong R, Liu P, Wee L, Butany J, Sole MJ. Verapamil ameliorates the clinical and pathological course of murine myocarditis. J Clin Invest 1992 90 : 2022 30.
20. Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK et al. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice. Circ Res 2005 97 : 380 90.
21. Abbate A, Bonanno E, Mauriello A, Bussani R, Biondi-Zoccai GG, Liuzzo G et al. Widespread myocardial inflammation and infarct-related artery patency. Circulation 2004 110 : 46 50. (Pubitemid 38880132)
22. Mazzulli T, Farcas GA, Poutanen SM, Willey BM, Low DE, Butany J et al. Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis 2004 10 : 20 4.
23. Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 2005 18 : 1 10. (Pubitemid 40128088)
24. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N et al. A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000 87 : E1 9.
25. Grant PR, Garson JA, Tedder RS, Chan PK, Tam JS, Sung JJ. Detection of SARS coronavirus in plasma by real-time RT-PCR. N Engl J Med 2003 349 : 2468 9.
26. de Lang A, Osterhaus AD, Haagmans BL. Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. Virol 2006 353 : 474 81.
27. Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, Sata T et al. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc Natl Acad Sci USA 2008 105 : 7809 14.
28. Wang S, Guo F, Liu K, Wang H, Rao S, Yang P et al. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Virus Res 2008 136 : 8 15.
29. Zhao X, Nicholls JM, Chen YG. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J Biol Chem 2008 283 : 3272 80.
30. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006 113 : 876 90.
31. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM et al. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol 2007 81 : 8692 706.
32. Cameron MJ, Bermejo-Martin JF, Danesh A, Muller MP, Kelvin DJ. Human immunopathogenesis of severe acute respiratory syndrome (SARS). Virus Res 2008 133 : 13 9.
33. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 2006 103 : 14194 9.